SCHEMBL6170122

SCHEMBL6170122

COC(=O)/C=C/c1ccccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.61
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
ELANE P08246 3/20 0.48
PRTN3 P24158 2/20 0.48
KMT2A Q03164 3/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
SLC16A3 O15427 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
HPGD P15428 1/20 0.45
CRHBP P24387 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403296 1.00 SNCA (0.61) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL18069272 0.87 MEN1 (0.50) SNCACYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL6170396 0.86 METAP2 (0.57) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL6169289 0.86 METAP2 (0.54) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL6169064 0.86 KEAP1 (0.49) SNCAKEAP1NFE2L2KMT2AALDH1A1
SCHEMBL6169068 0.86 KEAP1 (0.49) SNCAKEAP1NFE2L2KMT2AALDH1A1
SCHEMBL6169283 0.86 METAP2 (0.54) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL6170402 0.86 METAP2 (0.57) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL8120283 0.85 SNCA (0.56) SNCAKEAP1NFE2L2CYP2C9CYP2C19
SCHEMBL8120286 0.85 SNCA (0.56) SNCAKEAP1NFE2L2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed